content/02.introduction.md:145:infodemics
content/20.treatments.md:327:DSHEA
content/20.treatments.md:330:labelling
content/20.treatments.md:331:EFSA
content/20.treatments.md:332:EFSA
content/20.treatments.md:354:phagocytosis
content/20.treatments.md:356:hypothesised
content/20.treatments.md:361:antithrombotic
content/20.treatments.md:361:prothrombotic
content/20.treatments.md:362:antiplatelet
content/20.treatments.md:363:antiplatelet
content/20.treatments.md:363:investigational
content/20.treatments.md:364:antiplatelet
content/20.treatments.md:451:dimorphism
content/20.treatments.md:453:Biobank
content/20.treatments.md:454:Biobank
